ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

Research Base Would Be Increased In Guideline Change

November 9, 1990

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

NCI Funding Notice.

July 4, 2003